NPCE — NeuroPace Inc
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1528287 ·
Last close
$8.20
Market Cap
$282.50M
52W High
$19.60
52W Low
$5.46
ADV30
391,617
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 23,104,000 | 19,471,000 | -2,080,000 | -3,298,000 | 94,775,000 | 10,235,000 | 83,283,000 |
| Jun 2026 | 22,826,000 | 18,906,000 | -5,143,000 | -6,200,000 | 96,991,000 | 12,538,000 | 85,108,000 |
| Mar 2026 | 22,068,000 | 18,048,000 | -5,568,000 | -6,689,000 | 98,898,000 | 14,779,000 | 84,444,000 |
| Dec 2025 | 26,588,000 | 20,578,000 | -1,767,000 | -2,729,000 | 105,565,000 | 21,692,000 | 86,534,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,241,000
Investing CF
$-369,000
Financing CF
$1,410,000
CapEx
$-369,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.57
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-565,304,000
Inventory
$18,111,000
Receivables
$14,930,000
ST Investments
$39,161,000
EBIT TTM
$-12,809,000
Pretax Income TTM
$-19,114,000
Interest Exp TTM
$6,305,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$106,746,000
EBITDA
$-9,906,000
Free Cash Flow
$-2,411,625
Enterprise Value
$280,762,880
Total Cash
$49,231,000
Total Debt
$69,540,000
Shares Out
34,451,570
Trailing EPS
$-0.56
Book Value
$0.33
ROE
-97.0%
ROA
-6.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 99,986,000 | -16,338,000 | -21,465,000 | 105,565,000 | 86,534,000 | 19,031,000 | -11,006,000 |
| Dec 2024 | 79,906,000 | -21,671,000 | -27,141,000 | 94,647,000 | 86,634,000 | 8,013,000 | -17,949,000 |
| Dec 2023 | 65,421,000 | -27,174,000 | -32,956,000 | 107,651,000 | 86,997,000 | 20,654,000 | -19,701,000 |
| Dec 2022 | 45,520,000 | -40,794,000 | -47,082,000 | 114,106,000 | 79,329,000 | 34,777,000 | -36,869,000 |
TTM Snapshot
Revenues TTM
$98,836,000
NetIncome TTM
$-19,114,000
OpCashFlow TTM
—
Assets (Latest)
$96,991,000
Forward EPS
$-0.30
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $8.22 · call volume: 113 · put volume: 17
Expected Move to 2026-12-18:
±$1.37
(16.67%) —
implied range
$6.85 –
$9.59
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $288.75M | $4.44 | — |
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
| INFU | InfuSystem Holdings, Inc | $296.30M | $14.79 | — |
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
| SMTI | Sanara MedTech Inc. | $300.55M | $32.73 | — |
News headlines (Yahoo Finance, 1h cache)
Is NPCE Worth Buying Now as Growth Potential Meets Execution Risk?
2026-11-17 15:48 · Yahoo
NeuroPace (NPCE) Stock Fair Value Falls After Analysts Cut Targets On Q3 Miss
2026-11-16 12:10 · Yahoo
NeuroPace, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
NeuroPace (NPCE) Q3 2026 Earnings Call Transcript
2026-11-13 05:43 · Yahoo
What NeuroPace (NPCE) Said on Its Q3 Earnings Call
2026-11-13 04:14 · Yahoo
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Misses Revenue Estimates
2026-11-12 21:25 · Yahoo
NeuroPace Inc.: Q3 Earnings Snapshot
2026-11-12 21:13 · Yahoo
NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026
2026-10-29 20:05 · Yahoo
Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?
2026-09-10 15:30 · Yahoo
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
2026-09-04 13:58 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-11-17 17:08:22 | 2026-11-17 | Becker Joel | CEO | P - Purchase | 8.35 | 11891 | 99293 |
| 2026-11-17 17:10:42 | 2026-11-17 | Williams Patrick F. | CFO | P - Purchase | 8.34 | 11891 | 99148 |